#patent-settlement

[ follow ]
#pharmaceutical-litigation #lipid-nanoparticle-technology #covid-19-vaccines #intellectual-property
fromIPWatchdog.com | Patents & Intellectual Property Law
1 week ago

Moderna Settles with Genevant and Arbutus, Ending LNP Patent Dispute

The settlement resolves all U.S. and international patent litigation concerning the unauthorized use of Genevant's and Arbutus' lipid nanoparticle (LNP) delivery technology in Moderna's COVID-19 vaccines. The agreement came just days before a highly anticipated jury trial was scheduled to begin in the U.S. District Court for the District of Delaware.
Intellectual property law
Business
from24/7 Wall St.
1 week ago

Moderna and Ross Stores Lead Stock Gainers on Wednesday

Moderna surges 8.9% after settling a $2.25 billion patent dispute with Arbutus and Genevant over lipid nanoparticle technology, eliminating future royalty obligations and litigation risks for its mRNA pipeline.
Tech industry
fromTechCrunch
3 months ago

Samsung Display, China's BOE settle OLED patent and trade secret lawsuits | TechCrunch

Samsung Display and BOE Technology agreed to settle their three-year OLED patent and trade-secret disputes and will withdraw all pending legal actions.
[ Load more ]